Working… Menu

Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00051298
Recruitment Status : Completed
First Posted : January 9, 2003
Last Update Posted : June 12, 2007
Information provided by:
Eli Lilly and Company